With trust in the emerging digital health products being essential to their adoption, regulatory oversight offers a robust path for digital health product developers to demonstrate the safety and efficacy of their solutions. Regulatory oversight also opens the door to additional reimbursement pathways. However, there is uncertainty among digital health product developers, their clinical partners, and digital health investors. This document illustrates the value of digital health regulations along with 3 illustrative examples.
Communication Toolkit
Use this toolkit to better understand the formal and informal engagement options and resources to best communicate with FDA.